Crystal Bridge Enterprises
C$0.100000
0
+C$0.00+0%Tuesday 16:06
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
2.18M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
AlphaCognition, Inc., a biopharmaceutical company, discovers and develops bioactive compounds for treatments of Alzheimer's and Lou Gehrig's disease. It develops Alpha-1062, for the treatment of mild to moderate Alzheimer's disease, and Alpha-602, for the treatment of amyotrophic lateral sclerosis (ALS). The company was formerly known as Neurodyn Cognition Inc. and changed its name to AlphaCognition, Inc. in March 2020. The company was incorporated in 2014 and is based in Vancouver, Canada with additional offices in Charlottetown, Canada; and West Palm Beach, Florida.
Show More
CEO
Mr. Kenneth Anthony Cawkell B.A., LL.B.
Country
Canada
ISIN
CA2290721034
Listings
0 Comments
Share your thoughts
FAQs
What is Crystal Bridge Enterprises stock price today?▼
The current price of CRYS-P.V is C$0.10 CAD — it has increased by +0% in the past 24 hours. Watch Crystal Bridge Enterprises stock price performance more closely on the chart.
What is Crystal Bridge Enterprises stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on TSX Venture Exchange exchange Crystal Bridge Enterprises stocks are traded under the ticker CRYS-P.V.
What is Crystal Bridge Enterprises market cap?▼
Today Crystal Bridge Enterprises has the market capitalization of 2.18M
In which sector is Crystal Bridge Enterprises located?▼
Crystal Bridge Enterprises operates in the Finance & Payments sector.
When did Crystal Bridge Enterprises complete a stock split?▼
The last stock split for Crystal Bridge Enterprises was on March 31, 2021 with a ratio of 1:7.14.
Where is Crystal Bridge Enterprises headquartered?▼
Crystal Bridge Enterprises is headquartered in Vancouver, Canada.